This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Drugs Feeling Poorly as Investors Finding Their Way Back to Techville

Defensive issues were under pressure today as money jumped back into riskier stocks.

The American Stock Exchange Pharmaceutical Index was down 2.2%, with just about every component moving to the downside.

Yesterday, IMS Health (RX) reported that sales of prescription drugs rose 15%, to $145.1 billion in 2000. Today, the stock has moved a little higher, gaining 0.7% to $26.84.

Pfizer (PFE - Get Report) was the leader in annual U.S. sales, but today the stock was off 1.8% to $43.04. The company announced that it promoted Karen Katen, its current president of U.S. pharmaceuticals, to become the new president of its pharmaceuticals group and executive vice president of the entire company.

American Home Products (AHP - Get Report) also shook up its leadership a bit, naming Robert Essner its chief executive. Essner will keep his current title of president. The stock was down 3.8% to $59.53.

Blue-chip drug stocks -- Johnson & Johnson (JNJ - Get Report) and Merck (MRK - Get Report) -- were contributing the most drag to the Dow .

Still maintaining its rally was the Philadelphia Stock Exchange Semiconductor Index, up 6.9%.

Yesterday, the sector was boosted on feelings that chipmakers had been battered enough, and that they had hit a bottom. They jumped, with help from bargain hunters who shrugged off negative research notes.

Chipmakers gains were also helpful to the stocks of companies that use them, including the Nasdaq Telecommunications Index, 2.9% higher, and the Philadelphia Stock Exchange Computer Box Maker Index, up 6.2%.

And software stocks were flying along with most of tech. In the past few weeks, software stocks got smothered as their customers issued warning after warning. Software giant Microsoft (MSFT) was rising 3.4% to $59.44.

Veritas Software (VRTS), which makes data management software, was bouncing 11.2% to $66.50 in spite of having its price target cut to $110 from $175 by Prudential Securities.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
AHP $15.41 0.00%
JNJ $91.31 0.00%
MRK $51.59 0.00%
PFE $31.37 0.00%
AAPL $109.27 0.00%


Chart of I:DJI
DOW 16,102.38 -272.38 -1.66%
S&P 500 1,921.22 -29.91 -1.53%
NASDAQ 4,683.9190 -49.5780 -1.05%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs